ResMed (NYSE:RMD) has added autoEPAP to its Astral life support ventilator in the United States.
AutoEPAP (automatic expiratory positive airway pressure) automatically adjusts a patient’s expiratory pressure in response to flow limitations or obstruction of the upper airway. It’s an option when in Astral’s iVAPS (intelligent volume-assured pressure support) mode that automatically adapts to a patient’s changing pressure needs as their respiratory disease progresses.
AutoEPAP is already in use in other markets.
Resmed has added two more upgrades. Astral users worldwide can now easily change between a mouthpiece and a full mask, nasal or pillows mask from a single limb circuit, and clinicians can now name programs on a patient’s Astral device for fast, easy access, according to a company statement.
“These significant upgrades make Astral one of the most advanced life support ventilators on the market,” said Richie McHale, president of ResMed’s respiratory care business, in the statement. “Today’s innovations offer greater ease of use and even more peace of mind to patients across a wide range of respiratory diseases than ever before.”
Resmed also recently entered a joint venture withGoogle (NSDQ:GOOG) life sciences company Verily to develop software solutions to improve diagnosis, treatment and care for sleep apnea and other breathing related sleep disorders.